Congressman Cohen Applauds National Institutes of Health on New Guidance on Monoclonal Antibody Treatment for COVID Patients

September 27, 2021
Press Release
NIH revised policy after Cohen letter to President Biden

WASHINGTON – Congressman Steve Cohen (TN-09) today applauded a decision by the National Institutes of Health (NIH) to change its guidance on the use of monoclonal antibodies to treat COVID-19 patients in line with recommendations he made in a letter to President Biden last week.

Congressman Cohen urged the president not to prioritize those who have not been vaccinated over the vaccinated for the monoclonal antibody therapy. See that letter here.

On its website, updated over the weekend, the NIH now recommends:

“For people who develop COVID-19 after receiving SARS-CoV-2 vaccination, prior vaccination should not affect treatment decisions, including the use of and timing of treatment with monoclonal antibodies.”

Congressman Cohen reacted to the change in a statement today:

“I am pleased that the NIH has updated its guidance so that the unvaccinated and vaccinated are each treated with the appropriate medical intervention. This is the right policy. People should be treated with antibodies regardless of their vaccination status.”